Immunising against meningococcal serogroup Y using proteins

• 1. 利用蛋白质进行针对脑膜炎球菌血清群Y的免疫 [P] . 中国专利： CN1946420B . 2011.02.16
• 2. 利用蛋白质进行针对脑膜炎球菌血清群Y的免疫 [P] . 中国专利： CN1946420A . 2007-04-11
• 3. Immunising against meningococcal serogroup Y using proteins [P] . 美国专利： US10195264B2 . 2019-02-05

  机译： 使用蛋白质免疫针对脑膜炎球菌血清群Y

• 4. IMMUNISING AGAINST MENINGOCOCCAL SEROGROUP Y USING PROTEINS [P] . 欧洲知识产权局专利： EP1737486B1 . 2013-02-27

  机译： 用蛋白对免疫球蛋白血清群的免疫

• 5. IMMUNISING AGAINST MENINGOCOCCAL SEROGROUP Y USING PROTEINS [P] . PT1737486E . 2013-05-15

  机译： 用蛋白对免疫球蛋白血清群的免疫

• 1. Preparation and Immunogenicity of Serogroup B Meningococcal OS-OMPC Conjugates [J] . SUN YIN-YAN, HU XU-JING 生物医学与环境科学（英文版） . 1999,第004期
• 2. Genotypic Analysis, Construction of the Expression System and Immunological Identification of the Recombinant Proteins of the LipL32 Gene in the Dominant Serogroups of Leptospira interrogans in China [J] . 范兴丽, 严杰, 毛亚飞, 中华微生物学和免疫学：英文版 . 2004,第001期
• 3. Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules [J] . Biolchi Alessia, Tomei Sara, Santini Laura, Human vaccines & immunotherapeutics. . 2019,第3期
• 4. Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016 [J] . Dirk Mentzer, Doris Oberle, Brigitte Keller-Stanislawski Eurosurveillance . 2018,第17期
• 5. No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales [J] . The Lancet infectious diseases . 2006,第10期
• 6. Fatal meningococcal meningitidis in a baby caused by serogroup C Neisseria meningitidis belonging to ST-4821 complex [C] . Hui Han, Haishan Li, Yu Yang, International Conference on Human Health and Medical Engineering. . 2014
• 7. Studies on the pathogenic Neisseria: Characterization of H.8 lipoproteins and identification of a mouse genetic locus (Lps) affecting susceptibility to meningococcal infection. [D] . Woods, Jon Pointon. 1989
• 8. Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population a decade after vaccine introduction in the National Immunisation Programme [O] . Paulo Gonçalves, Emma Sáez-López, Sofia Carneiro, 2021
• 9. Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease [O] . Robyn Harrison, Robert Stirling, Oliver Baclic, 2020

• 1. Mandatory meningococcal vaccine,and other recommended immunisations:Uptake,barriers,and facilitators among health care workers and trainees at Hajj [J] . Al-Mamoon Badahdah123 ,Mohammad Alfelali123 ,Amani S Alqahtani4 . 世界临床病例杂志 . 2018,第016期
• 2. Proteoliposome and Polysaccharide-Based Meningococcal Vaccine Are Immunogenic in Infants and Toddlers and Primes for Memory against Serogroup C Polysaccharide [J] . Oliver Pérez ,Belkis Romeu ,Judith del Campo . 疫苗（英文） . 2013,第2期
• 3. Fatal meningococcal meningitis in a 2-year-old child: A case report [J] . Aleksander Mularski1 ,Czeslaw Zaba2 . 世界临床病例杂志 . 2019,第005期
• 4. 三种不同载体的C群脑膜炎球菌荚膜多糖-蛋白质结合疫苗比较研究 [C] . 吴兵 ,刘方蕾 ,杜琳 . 第八次全国生物制品学术会议 . 2005
• 5. 百日咳杆菌的免疫蛋白质组学研究以及应用生物信息学方法筛选针对百日咳的新抗原和药物靶点 [A] . 朱泳璋 . 2007